InvestorsHub Logo
Followers 230
Posts 15196
Boards Moderated 0
Alias Born 03/30/2005

Re: Gohel Yoerselph post# 339237

Sunday, 01/10/2021 8:25:33 AM

Sunday, January 10, 2021 8:25:33 AM

Post# of 402802
It's called alloprime. forget the name of the company. My point of posting the collaboration is it's an indirect benefit to IPIX. If you read the PR put out by GMU and the one put out by NLS, and look at what IPIX has said about GMU furthering research on Brilacidin, IMHO it's a pretty solid fit. We need expedited pre-clinical research and that seems to be what NLS can provide

the above is all IMHO (consider this my safe harbor statement)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News